Treatment with SODs, encapsulated SODs, liposomal SOD preparations, and recombinant manganese superoxide dismutase, MnSOD, resulted to offer antioxidant protection in fibrosis models; however, these compounds developed some immunogenic complications (Kinnula and Crapo, 2003). The gene discussed is SOD2; the disease is fibrosis.